3,4-Dichloro-2-methoxypyridine, 96%, 250mg

Sodium tert-butoxide solution 2M in THF, 98%, 100ml

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,4-oxadiazole, 95.0%, 250mg

2-((3-Aminophenyl)sulfonyl)ethan-1-ol, 98%, 5g

4,4,4-Trifluorocrotonamide, 95.0%, 25g

3-Chloro-5-(trifluoromethyl)pyridine-2-carboxaldehyde, 97.0%, 1g

1-(4-Bromophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid, 95+%, 250mg

1-Dodecylpyrrolidin-2-one, 95.0%, 100g

Ethyl 2,4-dibromobutanoate, 95.0%, 1g

4,5-Dimethyl-1H-benzo[d]imidazole, 97.0%, 250mg

2-Benzyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>97.0%(GC)5g

2-(5-PHENYL-4-(PYRIDIN-4-YL)-1H-1,2,3-TRIAZOL-1-YL)-N-(5-PHENYLPYRIDIN-2-YL)ACETAMIDE, 95%, 5mg

tert-Butyl 2-(4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-3-yl)acetate, 95%, 5g